Moxonidine, a Mixed α2-Adrenergic and Imidazoline Receptor Agonist, Identifies a Novel Adrenergic Target for Spinal Analgesia

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Moxonidine, a Mixed α2-Adrenergic and Imidazoline Receptor Agonist, Identifies a Novel Adrenergic Target for Spinal Analgesia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds

Arts & Humanities